Image guided radiation therapy (IGRT) is a new type of radiotherapy used to deliver lethal doses of radiation to mobile tumors, while preventing surrounding healthy structures from receiving high doses of radiation. It relies on image guidance to track the tumor and ensure its prescribed position in the radiation beam. The main goal
of this work was to determine if a new three-dimensional ultrasound (3D US) image
guidance device, called the Restitu System, could safely replace (or be used interchangeably with) an existing method involving x-ray images of implanted fiducial
markers (FMs) for prostate IGRT. Using comparison statistics called 95 % limits of
agreement (LOA), it was found that the new 3D US system did not produce measurements that agreed sufficiently closely to those made using the FM technique, and therefore, could not safely replace FMs for prostate IGRT. Ultrasound image quality and user variability were determined to have a significant impact on the agreement between the two methods. It was further shown that using the Restitu System offered no significant clinical advantages over a conventional patient re-positioning technique.
Identifer | oai:union.ndltd.org:uvic.ca/oai:dspace.library.uvic.ca:1828/889 |
Date | 23 April 2008 |
Creators | Johnston, Holly A. |
Contributors | Hilts, Michelle, Jirasek, Andrew |
Source Sets | University of Victoria |
Language | English, English |
Detected Language | English |
Type | Thesis |
Rights | Available to the World Wide Web |
Page generated in 0.0021 seconds